MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Home/Conditions/Irritable Bowel Syndrome (IBS)
Condition Guide

Irritable Bowel Syndrome (IBS)

Calming the gut-brain storm

IBS affects millions worldwide with symptoms that can be debilitating, yet the underlying cause has long been mysterious. New research points to the gut microbiome and the gut-brain axis as key drivers — and trials are finding promising paths to relief.

View Recruiting Trials

The Microbiome Connection

How Irritable Bowel Syndrome (IBS) relates to gut health

Common Symptoms

  • Bloating and gas
  • Abdominal cramping
  • Diarrhea, constipation, or alternating both
  • Urgency or incomplete bowel movements
  • Nausea

How the Microbiome is Involved

People with IBS often have a distinct microbiome signature — with reduced Bifidobacterium and Lactobacillus species and altered gut motility signals. The gut-brain axis plays a huge role: gut bacteria produce neurotransmitters like serotonin that directly affect bowel behavior and mood. Restoring microbial balance may calm both the gut and nervous system.

Active Trials

View all 108 trials
Efficacy of Pregabalin for Patients With Irritable Bowel SyndromeRecruiting
Irritable Bowel Syndrome (IBS)
To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).
Beijing, ChinaEst. completion Apr 8, 2026
View Trial →
Probiotics and Biomarkers in Irritable Bowel SyndromeRecruiting
Irritable Bowel Syndrome (IBS)
The goal of this double-blind parallel-arm randomized controlled trial is to learn if a probiotic supplement (containing…
Gothenburg, SwedenEst. completion Apr 2031
View Trial →
Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel SyndromeRecruiting
Diarrhea-predominant Irritable Bowel SyndromeIrritable Bowel Syndrome of Diarrhea Type (IBS-D)
This clinical study aims to investigate the effectiveness and safety of Gelsectan, a treatment containing xyloglucan, in…
Ho Chi Minh City, VietnamEst. completion Jul 30, 2026
View Trial →

Related Conditions

Inflammatory Bowel Disease (IBD)
Restoring balance to a disrupted gut
Explore
Small Intestinal Bacterial Overgrowth (SIBO)
When good bacteria end up in the wrong place
Explore
Mental Health & Gut-Brain Axis
The surprising conversation between your gut and your brain
Explore

Get notified about new Irritable Bowel Syndrome (IBS) trials

We’ll email you when new recruiting trials for your condition are posted. No spam, ever.